213 related articles for article (PubMed ID: 4063975)
1. Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.
Andrews PA; Murphy MP; Howell SB
Cancer Res; 1985 Dec; 45(12 Pt 1):6250-3. PubMed ID: 4063975
[TBL] [Abstract][Full Text] [Related]
2. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletion.
Andrews PA; Murphy MP; Howell SB
Mol Pharmacol; 1986 Dec; 30(6):643-50. PubMed ID: 3785141
[TBL] [Abstract][Full Text] [Related]
4. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF
Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194
[TBL] [Abstract][Full Text] [Related]
6. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
Goddard P; Valenti M; Kelland LR
Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
Chen G; Zeller WJ
Anticancer Res; 1991; 11(6):2231-7. PubMed ID: 1776864
[TBL] [Abstract][Full Text] [Related]
8. Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion.
Andrews PA; Schiefer MA; Murphy MP; Howell SB
Chem Biol Interact; 1988; 65(1):51-8. PubMed ID: 3345573
[TBL] [Abstract][Full Text] [Related]
9. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
[TBL] [Abstract][Full Text] [Related]
10. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
Perry RR; Greaves BR; Rasberry U; Barranco SC
Cancer Res; 1992 Sep; 52(17):4608-12. PubMed ID: 1511428
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Xu BH; Gupta V; Singh SV
Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
[TBL] [Abstract][Full Text] [Related]
13. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells.
Oguchi H; Kikkawa F; Kojima M; Maeda O; Mizuno K; Suganuma N; Kawai M; Tomoda Y
Anticancer Res; 1994; 14(1A):193-200. PubMed ID: 7909418
[TBL] [Abstract][Full Text] [Related]
14. Single step selection of cis-diamminedichloroplatinum(II) resistant mutants from a human ovarian carcinoma cell line.
McLaughlin K; Stephens I; McMahon N; Brown R
Cancer Res; 1991 Apr; 51(8):2242-5. PubMed ID: 1901242
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
Dusre L; Mimnaugh EG; Myers CE; Sinha BK
Cancer Res; 1989 Feb; 49(3):511-5. PubMed ID: 2535960
[TBL] [Abstract][Full Text] [Related]
16. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
Peters RH; Jollow DJ; Stuart RK
Cancer Res; 1991 May; 51(10):2536-41. PubMed ID: 2021933
[TBL] [Abstract][Full Text] [Related]
17. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
18. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B
Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994
[TBL] [Abstract][Full Text] [Related]
19. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
Crook TR; Souhami RL; Whyman GD; McLean AE
Cancer Res; 1986 Oct; 46(10):5035-8. PubMed ID: 3463410
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a Chinese hamster ovary cell line resistant to bifunctional nitrogen mustards.
Robson CN; Alexander J; Harris AL; Hickson ID
Cancer Res; 1986 Dec; 46(12 Pt 1):6290-4. PubMed ID: 3779647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
